FdaApplication
ANDA 205722
Identifiers
- fda_app_no: ANDA205722
Properties
| Property | Value |
|---|---|
| applicant_name | XELLIA PHARMACEUTICALS APS |
| application_type | ANDA |
| approval_date | 2019-10-18 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TIGECYCLINE | TIGECYCLINE | 50MG/VIAL | POWDER;INTRAVENOUS |
1 product